← Back to Episodes
PODCAST

Your Heart, Your Blood Pressure, and the Drug Your Doctor Just Prescribed

August 24, 2026·8:52·Episode 108

Quick Summary

This episode covers three new studies from the NAMS journal. First, a large cohort study showing that premature menopause combined with high blood pressure creates cardiovascular risk far beyond either condition alone. Then, a paper raising a largely invisible issue — how intimate partner violence shapes whether and how women access menopause care. And finally, real-world safety data on fezolinetant (Veozah), the non-hormonal hot flash drug, showing its clinical trial safety profile mostly holds up in the real world — with a few signals worth watching.

Your Heart, Your Blood Pressure, and the Drug Your Doctor Just Prescribed

0:000:00

Key Takeaways

  • Women who experienced premature menopause (before 40) AND have high blood pressure face cardiovascular risk significantly higher than either factor alone — making menopausal age a data point your cardiologist should know.
  • Most standard menopause care doesn't account for whether a woman is safe at home — and intimate partner violence directly affects whether she can access, afford, or safely use treatment.
  • Fezolinetant's (Veozah) real-world safety data broadly matches what clinical trials found, but there are disproportionate signals around liver and neurological events that warrant ongoing monitoring.
  • The fezolinetant pharmacovigilance analysis uses a WHO reporting database — it can flag patterns worth investigating, but it can't tell you how common these events actually are.
  • Knowing your age at menopause — especially if it was early — is medically relevant information for heart disease prevention, not just reproductive history.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.